Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster lunch

1876 - Higher expression of Micro-RNA and Wnt signaling cascade in RNASEL candidate gene in prostate cancer (562P)


18 Nov 2017


Poster lunch


Irfanullah Hijazi


Annals of Oncology (2017) 28 (suppl_10): x173-x176. 10.1093/annonc/mdx679


I. Hijazi1, M.N. Faisal1, A. Mahmood1, H. Muzaffar2, H. Nazir1, J. Hussain2

Author affiliations

  • 1 Department Of Pharmacy, Physiology And Pharmacology, University of Agriculture, Faisalabad, 38040 - Faisalabad/PK
  • 2 Institute Of Pharmacy, Physiology & Pharmacology, University of Agriculture, Faisalabad, 38040 - Faisalabad/PK


Abstract 1876


Cancer is a heterogeneous disease with worldwide distribution and aberrant alterations in gene expression. Prostate cancer is the result of considerable mutation in genome that are expressed in epithelial cells of prostate gland.


Current study guide us to identify the tools for detection of mutational signature in prostate gland and identified gene expression patterns was directed for targeted medical therapy and exploring the role of micro RNA and Wnt signaling cascade. Quantitative real time PCR was performed to determine the gene expression level.


Expression level of micro-RNA and Wnt signaling cascade in up regulation of RANSEL gene in prostate cancer was determined as well as FOXO is playing a key role. Results showed that the relative Mir 140, Mir 145 and Micro 328 genes expression level is significantly higher in prostate cancer patients which down regulate the FOXO 1 and FOXO 3 gene while as, TP53 expression is highly expressed in prostate cancer patients. The data was analyzed statistically by using ANOVA and DMR.


We concluded that Mir 140, Mir 145, Micro 328, FOXO 1, FOXO 3 and TP 53 genes expression level and Wnt signaling cascade play an important role in up regulation of RNASEL gene in prostate cancer.

Clinical trial identification

Legal entity responsible for the study

Ethical review Committee, Punjab Medical College, Faisalabad.




All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.